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Abstract
Background: The potential public health benefits of targeting environmental interventions by
genotype depend on the environmental and genetic contributions to the variance of common
diseases, and the magnitude of any gene-environment interaction. In the absence of prior
knowledge of all risk factors, twin, family and environmental data may help to define the potential
limits of these benefits in a given population. However, a general methodology to analyze twin data
is required because of the potential importance of gene-gene interactions (epistasis), gene-
environment interactions, and conditions that break the 'equal environments' assumption for
monozygotic and dizygotic twins.
Method:  A new model for gene-gene and gene-environment interactions is developed that
abandons the assumptions of the classical twin study, including Fisher's (1918) assumption that
genes act as risk factors for common traits in a manner necessarily dominated by an additive
polygenic term. Provided there are no confounders, the model can be used to implement a top-
down approach to quantifying the potential utility of genetic prediction and prevention, using twin,
family and environmental data. The results describe a solution space for each disease or trait, which
may or may not include the classical twin study result. Each point in the solution space corresponds
to a different model of genotypic risk and gene-environment interaction.
Conclusion: The results show that the potential for reducing the incidence of common diseases
using environmental interventions targeted by genotype may be limited, except in special cases. The
model also confirms that the importance of an individual's genotype in determining their risk of
complex diseases tends to be exaggerated by the classical twin studies method, owing to the 'equal
environments' assumption and the assumption of no gene-environment interaction. In addition, if
phenotypes are genetically robust, because of epistasis, a largely environmental explanation for
shared sibling risk is plausible, even if the classical heritability is high. The results therefore highlight
the possibility – previously rejected on the basis of twin study results – that inherited genetic
variants are important in determining risk only for the relatively rare familial forms of diseases such
as breast cancer. If so, genetic models of familial aggregation may be incorrect and the hunt for
additional susceptibility genes could be largely fruitless.
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Background
Some geneticists have predicted a genetic revolution in
healthcare: involving a future in which individuals take a
battery of genetic tests, at birth or later in life, to determine
their individual 'genetic susceptibility' to disease [1,2]. In
theory, once the risk of particular combinations of geno-
type and environmental exposure is known, medical
interventions (including lifestyle advice, screening or
medication) could then be targeted at high-risk groups or
individuals, with the aim of preventing disease [3].
However, there are also many critics of this strategy, who
argue that it is likely to be of limited benefit to health [4-
8]. One area of debate concerns the proportion of cases of
a given common disease that might be avoided by target-
ing environmental or lifestyle interventions to those at
high genotypic risk. Known genetic risk factors have to
date shown limited utility in this respect [9]. However,
some argue that combinations of multiple genetic risk fac-
tors may prove more useful in the future [10].
There are two possible approaches to considering this
issue. The 'bottom-up' approach seeks to identify individ-
ual genetic and environmental risk factors and their inter-
actions and quantify the risks. However, this approach is
limited by the difficulties in establishing the statistical
validity of genetic association studies and of quantifying
gene-gene and gene-environment interactions: see, for
example, [11-14].
A 'top-down' approach instead considers risks at the pop-
ulation level using twin and family studies and data on
the importance of environmental factors in determining a
trait. However, analysis of twin data is usually limited by
the assumptions made in the classical twin study [15],
including that: (i) there are no gene-gene interactions
(epistasis); (ii) there are no gene-environment interac-
tions; (iii) the effects of environmental factors shared by
twins are independent of zygosity (the 'equal environ-
ments' assumption). These assumptions have all been
individually explored and shown to be important in influ-
encing the conclusions drawn from twin and family data
[16-18]. In addition, the magnitude of any gene-environ-
ment interaction is critically important in determining the
utility of targeting environmental interventions by geno-
type [19]. Although a general methodology to analyze
twin data without making these assumptions has been
developed, the algebra becomes intractable once multiple
loci are involved [17]. This is problematic because, for
common diseases, the impacts of multiple genetic vari-
ants, and potentially the whole genetic sequence, on dis-
ease susceptibility (here called 'genotypic risk') may be
important.
The four-category model of population risks developed by
Khoury and others [19] is a useful starting point for a top-
down analysis of genetic prediction and prevention. It
allows the merits of a targeted intervention strategy
(which seeks to reduce the exposure of the high-risk gen-
otype group only) to be explored, and can readily be
extended to include more than four risk categories [10].
However, this model's use to date has been limited to bot-
tom-up consideration of single genetic variants or to stud-
ying hypothetical examples of multiple variants. The four-
category model is limited by the assumption of no con-
founders, which means it is applicable to only a subset of
possible models of gene-gene and gene-environment
interaction. However, situations where the 'no confound-
ers' assumption is valid are arguably most likely to be of
relevance to public health.
The aim of this paper is to combine the four-category
model with population level data from twin, family and
environmental studies, without adopting the classical
twin model assumptions. This model of gene-gene and
gene-environment interactions is then used to implement
a 'top-down' approach to quantifying the utility of genetic
'prediction and prevention'.
Method
The four-category model
Consider a population divided into genotypic or environ-
mental risk categories for a given trait (Figure 1a and 1b).
The fraction of the population in the 'high environmental
risk group' (designated by subscript e) is ε, and this sub-
population is at risk re. The remainder of the population
is at risk roe. The fraction of the population in the 'high
genotypic risk' group (designated by the subscript g) is γ,
and this subpopulation is at risk rg, with the remainder of
the population at risk rog. The total risk rt for this trait in
this population is then given by:
rt = γrg + (1-γ)rog   (1)
or by:
rt = εre + (1-ε)roe   (2)
The same population can alternatively be divided into
four categories, making a four-category model (Figure
1c)) with risks Roo, Roe, Rgo and Rge. Table 1 shows the risk
categories in this model.
The risks are related to the previous definitions by:
rg = εRge + (1-ε) Rgo   (3)
rog = εRoe + (1-ε) Roo   (4)Theoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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re = γRge + (1-γ) Roe   (5)
roe = γRog + (1-γ) Roo   (6)
The category risks R remain constant in different popula-
tions (i.e. as ε and γ vary), provided there are no con-
founders. This assumption restricts the model to special
cases of gene-gene and gene-environment interaction.
Note that for a single genetic variant, rg corresponds to the
penetrance of the variant, and that in general (provided
Rge ≠ Rgo) this varies with the proportion of the population
in the high exposure group, ε, as has been observed
[20,21].
The total risk for the given trait is given by:
rt = γεRge + γ(1-ε)Rgo + ε(1-γ)Roe + (1-ε)(1-γ)Roo   (7)
The subpopulation of cases has different characteristics
from the general population: for example, it contains a
higher proportion of people from the 'ge' subgroup. The
relative risk for a person drawn randomly from a subpop-
ulation with the same genotypic and environmental char-
acteristics as the cases, RRcases, is given by the sum of the
relative risks for each category shown in Table 1:
Similarly, the relative risk for a person drawn randomly
from a subpopulation with the same genotypic character-
istics as the cases (but with the environmental characteris-
tics of the general population) is:
The relative risk for a person drawn randomly from a sub-
population with the same environmental characteristics
as the cases (but with the genotypic characteristics of the
general population) is:
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The four-category model Figure 1
The four-category model. A population divided into: (a) high and low genotypic risk categories (rg and rog); (b) high and low 
environmental risk categories (re and roe); (c) four categories based on combined genotypic and environmental risk.Theoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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Population attributable fractions
Provided there are no confounders, the population attrib-
utable fraction (PAFE
e) due to the presence of the high
exposure (E) in the high exposure population subgroup
(e) may be defined as:
If the trait is a disease, PAFE
e is the proportion of cases that
could be avoided if an environmental intervention (such
as a lifestyle change or reduction in exposure) succeeds in
moving everyone in the 'high environmental risk group'
to the 'low environmental risk' category, as shown in Fig-
ure 1b.
The targeted population attributable fraction (PAFE
ge)
may be defined as the proportion of cases that could be
avoided by targeting the same environmental interven-
tion at the 'high genotypic + high environmental risk' sub-
group only (the 'ge' subgroup), as shown in Figure 1c.
Again assuming no confounders, it is given by:
Note that PAFE
ge differs from PAFge as defined by Khoury
& Wagener [19]. The latter implicitly assumes that both
environmental and genetic risk factors are reduced and
thus is inappropriate for assessing the merits of a targeted
environmental intervention. PAFE
ge  as defined here is
instead equivalent to the targeted attributable fraction
(AFT) defined by Khoury et al. [10]. To avoid confusion,
the notation adopted here specifies both the nature of the
intervention (environmental, denoted by superscript E)
and the target subpopulation (the 'ge' subgroup, at both
high genotypic and high environmental risk). Thus, the
proportion of cases that would be avoided were it possible
to move the 'high genotypic risk' subgroup to 'low geno-
typic risk' (as shown in Figure 1a) is written as PAFG
g,
given by:
Although in practice it is not possible to change the geno-
type of the population, the parameter PAFG
g is neverthe-
less useful in the calculations that follow.
Measures of utility
Khoury et al. [10] define the Population Impact (PI) as:
PI is one possible measure of the usefulness of targeting
the environmental intervention (E) at the 'ge' subgroup. It
measures the proportion of cases avoided by targeting the
'high genotypic + high environmental risk' subgroup (the
'ge' subgroup), compared to the proportion avoided by
applying the environmental intervention to the whole
'high environmental risk' group. PI has the property:
0 ≤ PI ≤ 1   (15)
and has its maximum value when PAFE
ge = PAFE
e. How-
ever, as a measure of the utility of genotyping, PI has the
disadvantage that it takes no account of the proportion of
the population γ in the high genotypic risk group. This
means PI = 1 when γ = 1 simply because the whole popu-
lation is then in the high genotypic risk group, although
using genotyping to target environmental interventions is
more likely to be useful if PI = 1 and γ is also small.
Therefore, consider an alternative utility parameter Uge,
defined by:
which has the property
-γ ≤ Uge ≤ (1-γ)   (17)
Uge tends to 1 only if PI = 1 and γ is also small. It is a meas-
ure of the utility of using genotyping to target the environ-
mental intervention at the 'ge' subgroup, compared to
randomly selecting the same proportion γ of the popula-
tion to receive the intervention. Uge is positive if those at
high genotypic risk have more to gain than those at low
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Table 1: The four category model: risks and cases for a population of size N.
Category Risk of being in category Number of people in category Number of cases in category
ge (high-risk genotype/high-risk exposure) Rge γεN γε RgeN
go (high-risk genotype/low-risk exposure) Rgo γ (1-ε)N γ (1-ε)RgoN
oe (low-risk genotype/high-risk exposure) Roe ε (1-γ)N ε (1-γ)RoeN
oo (low-risk genotype/low-risk exposure) Roo (1-ε) (1-γ)N (1-ε) (1-γ)RooN
Total Nr tNTheoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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genotypic risk from the intervention ((Rge-Rgo)  ≥ (Roe-
Roo)) and negative if they have less to gain from the inter-
vention. This reflects the fact that targeting those who
have least to gain through an intervention is worse than
using random selection in terms of its impact on popula-
tion health.
Note that even if genotyping is better than random selec-
tion, other types of test that are more useful may be avail-
able [22]; a population-based approach still has the
potential to reduce more cases of disease [9,19,23]; and
such targeting also has broader psychological and social
implications. Therefore a positive Uge does not necessarily
imply that genotyping is the best means of selecting a sub-
population to target, or that a targeted approach is neces-
sarily effective or socially acceptable. Note also that the
measure Uge applies only to interventions that are consid-
ered applicable to the whole population (such as smoking
cessation) and neglects other relevant issues such as cost-
effectiveness and the burden of disease [24]. In addition,
it is necessary to consider the magnitude of the Popula-
tion Attributable Fraction, PAFE
e before proposing this
approach. This is because both PI and Uge may tend to
unity even if only a small proportion of cases can be
avoided by means of environmental interventions.
Limits on parameters
Consider only populations where rg ≥ rog and re ≥ roe for all
values of ε and γ. Then the risks in the four box model
must be ordered such that:
1 ≥ Rge ≥ Roe ≥ Roo ≥ 0   (18)
and
Rge ≥ Rgo ≥ Roo   (19)
Using the known relationships (Equations (11), (13) and
(16)) between PAFE
e, PAFG
g, Uge and the risks Roo, Rgo, Roe
and Rge, leads to the limits on the utility parameter Uge
shown in Table 2. These conditions also ensure that PAFE
e,
PAFG
g and PAFE
ge are all positive. The two remaining ine-
qualities (Rge ≤ 1 and Roo ≥ 0) are considered later, where
they are used to derive limits on the proportion of the
population in the 'high genotypic risk' group, γ. This step
is not possible at this stage because PAFE
e, PAFG
g and
PAFE
ge are themselves dependent on γ.
The twin and familial risks model
Data from studies of monozygotic and dizygotic twins are
commonly used to estimate the genetic and environmen-
tal variances Vg and Ve of a trait. Here, the aim is to use
twin and other data to estimate the possible magnitudes
of the population attributable fractions and measures of
utility defined above. To do this it is necessary to estimate
Vg, Ve and the variance due to gene-environment interac-
tion, Vge. The standard methodology for twin data analysis
is inappropriate because it assumes Vge = 0.
First note that we are interested in the extent to which rel-
atives share risk categories (which may be either environ-
mental or genotypic, or both), rather than a particular
genetic variant. The probability that a relative of a
proband is also a case depends on the extent to which
their environmental and genotypic risks are correlated
with those of the proband. Rather than adopting a specific
form for the genetic model, define prel
g as the correlation
in genotypic risk category (g) between relatives of type
denoted by the superscript 'rel'. The parameter prel
g is the
probability that the genotypic risk category (high or low)
is identical by descent.
For monozygotic (MZ) twins, assumed to share their
entire genome, pMZ
g = 1. For dizygotic (DZ) twins and
other siblings, who share half their genome, pDZ
g = psib
g =
1/2 for a single allele model (dominant Mendelian disor-
der) or an additive polygenic model. For a two allele
model (recessive Mendelian disorder) or the dominance
term of a polygenic model (in which multiple pairs of
alleles interact), pDZ
g = psib
g = 1/4. Here, allowing for the
possibility of multiple gene-gene interactions (epistasis),
require only that:
The meaning of pDZ
g and its relationship to the polygenic
risk model first adopted by Ronald Fisher in 1918 is dis-
cussed further below.
Similarly, define prel
e as the correlation in environmental
risk category (e) between relatives of type "rel", requiring
only that:
Assume that prel
g and prel
e are independent (so that there
is no genotype-environment correlation) and that risks
within a category are randomly distributed. The relative
risk for a relative of type "rel" may then be written:
Substituting for the relative risks RRcases
gen, RRcases
env and
RRcases using Equations (8), (9) and (10) leads (after some
algebra) to:
where
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Note that if the G-E interaction component of the vari-
ance, Vge, is zero, the utility of targeting the environmental
intervention by genotype, Uge, is also zero (Equation
(26)), because those at high genotypic risk have no more
to gain from the intervention than those at low genotypic
risk (Rge-Rgo = Roe-Roo).
Equation (23) can also be derived more formally using
matrix methods (Appendix A).
The gene-environment interaction factor and remaining 
inequalities
Without loss of generality, define the gene-environment
interaction factor fge such that:
and choose its sign so that (combining Equations (24),
(25) and (26)):
Uge is zero if fge = 0 (i.e. for an additive G-E model, with no
G-E interaction), but for a given γ and Vg, Uge increases
with increasing gene-environment interaction factor, fge.
For a fixed fge and genetic variance component Vg, Uge is
maximum when γ = 1/2, i.e. when half the population is
in the high genotypic risk group, provided solutions with
γ = 1/2 exist (see also below: cases where γmaxge < 1/2).
Using the definitions of Ve, Vg and Vge (Equations (24),
(25) and (26)) and the remaining inequalities, Rge ≤ 1 and
Roo ≥ 0, two limits can be derived on the proportion of the
population in the 'high genotypic risk' group, γ (see Table
2).
Scoping studies
The general system of equations represented by Equation
(23) may be simplified where data exist from monozy-
gotic twins, dizygotic twins and other siblings, such that
λDZ > λsib. This implies that environmental risks are more
strongly correlated in dizygotic twins than in other sib-
lings, pe
DZ > pe
sib. Remembering that pMZ
g = 1 and psib
g =
pDZ
g, three independent equations for the relative risk in
monozygotic, dizygotic twins and siblings may then be
written:
To solve, assume the recurrence risks λ are known (see
Appendix B and [25]) and define:
with
RMD ≥ 1   (34)
and
0 ≤ RSD ≤ 1.   (35)
Note that if RSD = 1, Equations (30) and (31) are identical,
pe
DZ = pe
sib, and more relatives are needed to obtain solu-
tions, except in the special case where there is no environ-
mental variance (see below: no environmental variance).
In addition, define the variable parameters (assumed
unknown):
with
cMD ≥ 1   (38)
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and
0 ≤ cSD ≤ 1.   (39)
For λDZ > 1 and RSD < 1 the simultaneous Equations (29),
(30) and (31) can then be solved to give:
provided   ≠ 0,   ≠ 0 and cSD ≠ 1 (see also below).
For situations in which a targeted intervention is under
consideration, the population attributable fraction PAFE
e
and exposure ε are likely to be known, allowing Ve to be
treated as an input variable. However, pDZ
e is usually
unknown, since environmental correlations are often dif-
ficult to measure. Therefore, it is useful to eliminate pDZ
e
from Equations (41) and (42), leading to:
where
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Table 2: Constraints on model parameters
Condition Limits on Uge Limits on γ Limits on pDZ
g Limits on fge
Roe ≥ Roo Uge ≤ (1 - γ) γ ≤ γmax ge where 
Rgo ≥ Roo
Rge ≥ Rgo Uge ≥ -γ γ ≥ γneg where 
Rge ≥ Roe
Rge ≤ 1 γ ≥ γmin ge where 
Roo ≥ 0 γ ≤ γo where 
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Equations (27), (40) and (43) allow the gene-environ-
ment interaction factor fge to be written as:
The parameter pDZ
g, which defines the form of the genetic
model, is then given by:
For known RMD, RSD and λDZ a solution space can now be
mapped, which includes all possible variances consistent
with the data and with the inequalities derived above.
Requiring the variances to be positive leads to the addi-
tional conditions on pDZ
g and cSD shown in Table 3.
The limits on Uge shown in Table 2 set limits on the range
of gene-environment interaction models such that:
Noting that fge = 0 corresponds to pDZ
g = pDZ
gmin (Equation
(64)), this implies that, for Uge ≥ 0, the solution space may
be defined by:
where pDZ
gmax is given by Equation (47) with fge = 1/PAFE
e.
For Uge ≤ 0, the solution space may be defined by:
where pDZ
gneg is given by Equation (47) with fge = -ε/(1-
ε)PAFE
e.
The remaining limits on Uge lead to the additional condi-
tions on the range of γ values (the proportion of the pop-
ulation in the high risk group) shown in Table 2. These
conditions on γ may be written:
γmin ≤ γ ≤ γmax   (51)
where (noting that γmaxge = γo when fge = 1):
and (noting that γminge = γneg when fge = -rt/(1-rt)):
Two transition lines can therefore be defined such that
pDZ
g = pDZ
gt when fge = 1 and pDZ
g = pDZ
gnegt when fge = -rt/
(1-rt). The values of pDZ
gt and pDZ
gnegt may be calculated
using Equation (47).
The full range of gene-environment interaction models
specified by fge (within the limits given by Equation (48))
and the corresponding range of γ values are summarized
in Table 4. Note that the risk distribution associated with
fge = 1 corresponds to a multiplicative model of gene-envi-
ronment interaction. If fge ≥ 1 solutions with population
impact PI = 1 may exist (i.e. with PAFE
ge = PAFE
e), pro-
vided the proportion of the population in the high risk
genotypic group takes the maximum value consistent with
the data (γ = γmaxge). For lower values of fge, solutions with
PI = 1 cannot exist.
One additional condition is necessary for solutions to
exist, namely:
γmax ≥ γmin   (54)
This condition is always met if
λMD ≤ ye + 1   (55)
where
and F1 and F2 are given by:
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However, if λMD is greater than this, the requirement γmax
≥ γmin further restricts the values of cSD that lie within the
solution space (Table 3).
If Ve and ε are known, a solution space can be now be
mapped for pDZ
g and fge with known input data from twin
and sibling studies (λMZ, λDZ and λsib), for a given cMD and
all values of cSD within the assumed range. The boundaries
of the solution space are determined by the limits on fge
given by Equation (48), the condition γmax ≥ γmin (Equa-
tion (54)), and the requirement that pDZ
g is less than or
equal to 1/2 (Equation (20)) – no other condition on the
genetic model is specified a priori. For each genetic risk
model and gene-environment interaction model in the
solution space, defined by pDZ
g and fge respectively, the
variances Vg and Vge can then be calculated, as can γmax and
γmin. For a chosen γ value in the allowed range, Uge can
then be calculated from Equation (28).
The model code is available as [Additional file 1:
heritability12.xls].
Note that the condition on pDZ
g ≤ 1/2 may also be rewrit-
ten using Equation (47), so that:
which is always met if
Before mapping the solution space, first consider some
special cases and a comparison of the model with the clas-
sical twin studies approach.
Special cases
1. No genetic variance
If Vg = 0, Equation (27) implies that Vge = 0 also. Equations
(29), (30) and (31) then give:
RSD = cSD   (61)
and
RMD = cMD   (62)
Under the usual assumption that cMD = 1 (the 'equal envi-
ronments' assumption), this is the well-known result that
genetic variance can be zero only when the concordance
in monozygotic and dizygotic twins is the same (leading
to RMD = 1). However, if the equal environments assump-
tion is not met (cMD > 1), values of RMD greater than 1 do
not necessarily imply that a genetic component to the var-
iance exists (see, for example, [18]).
2. No environmental variance
If Ve = 0, Equation (27) implies that Vge = 0 also. Equations
(29), (30) and (31) then give:
RSD = 1   (63)
and
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Table 3: Further constraints on model parameters
Condition Limits on pDZ
g Limits on cSD
Ve ≥ 0
Vge ≥ 0
Vg ≥ 0 CSD ≤ RSD
γmax ≥ γmin If λMD > ye + 1 require:
cSD ≥ cSDm where
pp g
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For a purely genetic model with no environmental vari-
ance, Equation (64) implies that if RMD > 2, pDZ
g < 1/2.
This is consistent with Risch's finding [16] that neither an
additive genetic model nor a single dominant gene model
(both with pDZ
g = 1/2) can fit the data for conditions such
as schizophrenia (which has an RMD value significantly
greater than 2).
3. Classical twin study assumptions
Assuming no gene-environment interaction (Vge = 0); an
additive genetic risk model (pDZ
g = 1/2); and the 'equal
environments' assumption (cMD = 1) in Equations (29),
(30) and (31) gives:
This is the classical twin study result, assuming the domi-
nance term of the genetic variance is negligible. Note that,
if RMD = 2, the classical solution implies that the environ-
mental variance terms in Equations (29) to (31) are zero
and shared sibling risk is due to entirely to shared genes.
4. No correlation in genotypic risk in siblings (pDZ
g = 0)
Equation (20) allows pDZ
g to tend to zero. Substituting
pDZ
g = 0 in Equations (29), (30) and (31) and using the
definition of the gene-environment interaction factor
(Equation (28)) gives:
RSD = cSD   (66)
and
Note that, from Equations (30) and (31), pDZ
g = 0 corre-
sponds to a purely environmental explanation for shared
sibling risks (although there may remain a genetic compo-
nent to shared risks in monozygotic twins, from Equation
(29)). The solution pDZ
g = 0 may not exist in reality; how-
ever, the solution at this limit is of interest because low
values of pDZ
g are plausible.
Also, note that if fge = 0 (no gene-environment interac-
tion) and cMD = 1 (the 'equal environments' assumption),
the genetic variance Vg given by Equation (67) is half the
classical twin study result (Equation (65)).
5. Cases where γmax = γmin
If the line γmax = γmin exists within the solution space, some
special cases may arise with risk distributions of particular
interest (including, for example, a solution with Rge = 1
and all other risks zero). These special cases and the con-
ditions that they meet are shown in Table 5.
6. Cases where γmaxge < 1/2
Equation (27) shows that for a fixed gene-environment
interaction factor fge and genetic variance component Vg,
the utility Uge is maximum when γ = 1/2, i.e. when half the
population is in the high genotypic risk group, provided
this solution exists. However, if γmax < 1/2, utility is maxi-
mum when γ = γmax. As a smaller proportion of the popu-
lation is then targeted, these solutions are of particular
interest. Because solutions with population impact PI = 1
may exist when 1 ≤ fge ≤ 1/PAFE
e if γ = γmaxge (Table 4), it is
of interest to identify the area of the solution space with
V
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Table 4: Limits on the gene-environment interaction factor (fge) and the proportion of the population in the high-genotypic risk group (γ).
Gene-environment 
interaction model
Interaction 
factor fge
Risk distribution Utility Uge Fraction of population at high genotypic risk
Maximum γmax Minimum γmin
Genetic effect in high-
exposure group only
1/PAFE
e R00 Rge Positive γmaxge (where PAFE
ge = PAFE
e; 
PI = 1; and Uge = 1-γ).
γminge (where Rge = 1).
R00 R0e
Multiplicative 1 Rg0 Rg0R0e/R00 γmaxge = γ0 (where PAFE
ge = 
PAFE
e; R00 = 0; and PAFG
g = 1).
R00 R0e
Additive 0 Rg0 Rg0+R0e-R00 Zero γ0 (where R00 = 0).
R00 R0e
Reverse multiplicative -rt/(1-rt) Rg0 (1-Rg0) (1-R0e)/(1-R00) Negative γneg = γminge (where 
PAFE
ge = 0 and Rge = 1)
R00 R0e
Genetic effect in low-
exposure group only
-ε/(1-ε)PAFE
e Rg0 R0e γneg (where PAFE
ge = 0 
and PI = 0).
R00 R0eTheoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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γmaxge < 1/2. Maximum utility is then obtained when γ =
γmaxge (where PI = 1 and Uge = 1-γmaxge). For the condition
where pDZ
gx is given by:
solving for pDZ
gx allows the region of the solution space
where γmaxge < 1/2 to be defined.
7. Cases where the 'equal environments' assumption holds (cMD = 1)
In the special case where the 'equal environments'
assumption holds (cMD = 1, and hence pDZ
gtop = 1/RMD),
Equation (63) simplifies to give RMD ≥ 2. Equation (62)
also simplifies to give:
where
Meeting the condition pDZ
g ≤ 1/2 at cSD = 0 then requires:
It follows that if cMD = 1, solutions with pDZ
g = 1/2 (an
additive genetic model) and positive utility exist only
when the following condition holds for RMD:
Further, all three classical twin study assumptions (cMD =
1, pDZ
g = 1/2 and fge = 0) can be met only for values of RMD
that are low enough to satisfy:
1 + RSD ≥ RMD > 1   (74).
If RMD lies within this range, the classical twin study gives
one possible solution; however, other solutions also exist.
All alternative solutions favour a less 'genetic' and more
'environmental' explanation for shared sibling risks (i.e.
they have higher values of cSD). If RMD is greater than
1+RSD, all three assumptions of the classical twin study
cannot be met simultaneously.
Comparison with the classical twins approach
Table 6 summarizes the differences between the classical
twin studies approach and the method adopted here.
A central feature of the model is that it abandons Fisher's
assumption [26] that genes act as risk factors for common
traits in a manner necessarily dominated by an additive
polygenic term. In his historic 1918 paper, Fisher synthe-
sized Mendelian inheritance with Darwin's theory of evo-
lution by showing that the genetic variance of a
continuous trait could be decomposed into additive and
non-additive components [26,27]. Following Fisher, the
classical twin study analysis depends on writing the
genetic component of a trait as a convergent series of
terms, consisting of an additive term (the sum of contri-
butions of individual alleles at each locus) plus a smaller
dominance term (the sum of contributions from pairs of
alleles at each locus) and – usually neglected – epistatic
terms (involving potentially multiple interactions
between alleles at multiple loci) [15]. Often the additive
term is assumed to dominate the series (equivalent to
assuming pDZ
g = 1/2).
Fisher saw his polygenic model as "abandon  [ing]  the
strictly Mendelian mode of inheritance, and treat [ing] Gal-
ton's 'particulate inheritance' in almost its full generality" [26].
However, it can be argued that Fisher's model is flawed in
so far as it fails to distinguish between the function of alle-
les and the properties of traits [4,28]. In particular, epista-
sis (although referred to here as 'gene-gene interaction') is
not strictly an interaction between genes, but can be
shown to depend on the structure and interdependence of
metabolic pathways [28].
The alternative model adopted here is based on correla-
tions in risk categories for a trait (which may be either envi-
ronmental or genetic, or both), rather than single or
multiple genetic variants. Adopting Porteous' critique
[28], there is no a priori biological reason why the param-
eter pDZ
g (the probability that the genotypic risk category
of a dizygotic twin pair is identical by descent) cannot take
any value between 1/2 (its value if the additive model
holds) and zero. Low pDZ
g can then be understood to
mean either a situation in which Fisher's polygenic model
[26] is dominated by negative (synergistic) epistatic terms
(for example, pDZ
g  = 1/2n  implies that interactions
between n deleterious alleles are necessary to produce a
phenotypic effect), or, more meaningfully, a situation in
which human phenotypes are biologically robust to individ-
ual genetic variants [29]. Thus, in the extreme case where
numerous genetic variants combine to influence a trait
through the interdependence of metabolic pathways, the
trait may be highly correlated in monozygotic twins (who
share all the genetic variants) but not correlated at all
(pDZ
g = 0) in dizygotic twins or siblings (who share only
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Table 5: Special cases with γmax = γminfor Uge ≥ 0
Special cases with γmax = γmin Special cases with γmax = γmin and specific G-E interaction 
models
Special cases with γmax = γmin and all risks all 0 or 1
Risk distribution Conditions Population 
impact and 
Utility
Risk distribution Conditions Population 
impact and 
Utility
Risk distribution Conditions Population impact 
and Utility
11r t = 1 PAFe = 0 Undefined (PAFge = 0)
R00 1 γminge = γmaxge (Rge = 1 and PAFge = 
PAFe) fge = 1/PAFe
PI = 1 Uge = 1-γ 11
Rg0 1 γminge = γmaxge (Rge = 1 and 
PAFge = PAFe) fge ≥ 1
PI = 1 Uge = 1-γ R00 R00 01r t = γε PAFe = 1 PI = 1 Uge = 1-γ
R00 R00 Rg0 1 γminge = γ0 = γmaxge (Rge = 1; R00 = 
0; PAFge = PAFe) fge = 1
PI = 1 Uge = 1-γ 00
Rg0 1 γminge = γ0 (Rge = 1; R00 = 
0) 0 ≤ fge ≤ 1
0 = PI = 1 Uge = PI-γ 00 1 1 r t = γ PAFe = 0 Undefined (PAFge = 0)
0R 0e 1-R0e 1 γminge = γ0 (Rge = 1; R00 = 0) fge = 0 PI = γ Uge = 0 0 0
0R 0e 01r t = ε PAFe = 1 PI = γ Uge = 0
01
Table 6: Comparison with classical twin study
Classical twin study Twins + siblings model
Genetic model Additive and dominance terms only: VDZ
g = 1/2VA+1/4VD Variable: VDZ
g = pDZ
gVg with 0 < = pDZ
g < = 1/2
Shared twin environments Equal environments assumption: cMD = 1 Variable: 1 < = cMD < = RMD cMD = RMD implies Vg = 0
Shared sibling environments Siblings not included. Variable: 0 < = cSD < = RSD Familial aggregation may be due to genes (cSD 
= 0) or environment (cSD = RSD).
Gene-environment interactions None Variable: Vge = f2
ge· Vg· Ve/r2
t -ε/(1-ε)PAFe < = fge < = 1/PAFe
Gene-environment correlations None None
Method Total phenoptypic variance given by: VP = Vg+Ve VP is input and a single solution 
for Ve and Vg calculated. Heritabilities are given by: H2 = Vg/VP h2 = VA/VP
Ve and ε are input and Vg and Vge calculated, for a chosen cMD and all 
possible values of fge and pDZ
g. Method is not valid if RSD = 1.Theoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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half the relevant variants by descent). Although pDZ
g = 0
may not be realistic, low values of pDZ
g are plausible, and
may even be typical of complex diseases.
The classical twin study assumptions (see above) allow a
single solution to be calculated from the under-deter-
mined system of simultaneous Equations (29), (30) and
(31). However, in the absence of prior knowledge about
the form of the genetic model, the presence or absence of
gene-environment interactions, and the validity of the
'equal environments' assumption, the approach adopted
here is more rigorous.
Results
General model solutions
First consider the behaviour of the model when the 'equal
environments' assumption holds and hence cMD = 1 (as
described above).
Figures 2, 3 and 4 show the possible solution spaces for an
arbitrary set of plausible input parameters satisfying the
requirement RMD > 1+RSD necessary for the classical twin
study solution to exist. In Figure 2 the gene-environment
interaction factor fge and hence utility, Uge, are both posi-
tive and in Figure 3 they are negative. The horizontal axis
shows cSD/RSD, which is zero if shared sibling risk is due to
shared genetic factors only and 1 if shared sibling risk is
due to shared environmental factors only. The vertical axis
shows pDZ
g, which is 1/2 if the additive genetic model
holds, but may reduce to zero if epistasis dominates and
the phenotype is robust to genetic variation. The three
curved solid lines represent three models of gene-environ-
ment (G-E) interaction: an additive G-E model (i.e. no
gene-environment interaction, fge = 0); a multiplicative G-
E model (fge = 1); and maximum G-E interaction (fge = 1/
PAFE
e). The possible solution spaces are shaded grey. Each
point in each shaded solution space corresponds to a
Example model solution space with RMD < 1+RSD and Uge ≥ 0 Figure 2
Example model solution space with RMD < 1+RSD and Uge ≥ 0. Input parameters: λMZ = 3.4, λDZ = 3, λsib = 2, ε = 0.2, 
PAFE
e = 0.5, cMD = 1, rt = 0.1. Hence RMD = 1.2, RSD = 0.5.Theoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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given genetic model (defined by pDZ
g) and a given G-E
interaction model (defined by fge). Figure 4 plots the
entire solution space (including both negative and posi-
tive utility) by transforming the horizontal axis to repre-
sent the G-E interaction parameter, fge. Although the
classical twin model can fit the data, an infinite number of
other solutions corresponding to different genetic and
gene-environment interaction models also exist. In this
example, the line γmax = γmin lies outside the solution space
and no solutions exist with γmaxge < 1/2.
For lower values of RMD, the curves defining the solution
space are shifted downwards [see Additional files 2 to 9],
so that the line fge = 0 (corresponding to no gene-environ-
ment interaction) lies entirely below the line pDZg = 1/2
(corresponding to an additive genetic model). The classi-
cal twin study solution does not exist, but many other
combinations of genetic and gene-environment interac-
tion models may fit the data.
When cMD > 1, lines of constant fge no longer decrease
monotonically to zero, and are also shifted upwards, so
that solutions with strong G-E interactions are no longer
possible [see Additional files 10 to 12].
Example applications using twin, sibling and 
environmental data
Input values
Consider example applications of the model for male
lung cancer, female breast cancer and schizophrenia. The
model input variables used are shown in Table 7.
The recurrence risks, λ, and total risks, rt, for breast and
lung cancer are those calculated by Risch [30], based on
Example model solution space with RMD < 1+RSD and Uge ≤ 0 Figure 3
Example model solution space with RMD < 1+RSD and Uge ≤ 0. Input parameters as for Figure 2.Theoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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Scandinavian twin data reported by Lichtenstein et al.
[31] (involving more than 44,000 twin pairs) and Swed-
ish familial data reported by Doug and Hemminki [32]
(involving more than 2 million families). The proportion
of the population exposed, ε, and population attributable
fraction, PAFE
e, for breast cancer are taken from those
reported by Rockhill et al. [33] for a US population.
Although strictly speaking these values may not be appro-
priate for a Scandinavian population, and include a com-
ponent due to family history that may be (at least partly)
genetic, they give a low Ve, consistent with the known
environmental risk factors for breast cancer, and results
are not sensitive to these input values (because Ve is so
small). For lung cancer, it is assumed that 15% of the
Scandinavian population smokes and that 86% of lung
cancer cases could be avoided if they did not (giving a risk
of lung cancer in smokers of 10%).
The recurrence risks λ, and total risk, rt, for schizophrenia
are those used by Risch [16], based on European data
summarized by McGue et al. [34]. More recent twin stud-
ies for schizophrenia have given variable results and this
example should be treated as illustrative only. Further,
environmental exposures and population attributable
fractions are unknown for schizophrenia. Two explora-
tory sets of results are therefore reported, using data con-
sistent with a low environmental variance (based on the
values used for breast cancer), and high environmental
variance (based on the values used for smoking and lung
cancer).
Detailed results for the three diseases are shown in [Addi-
tional file 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25,
26, 27, 28, 29, 30, 31, 32, 33]. The key findings are out-
lined below.
Example full model solution space with RMD < 1+RSD Figure 4
Example full model solution space with RMD < 1+RSD. Input parameters as for Figure 2, with the solution space trans-
formed so that fge is on the horizontal axis.Theoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
Page 16 of 24
(page number not for citation purposes)
Breast cancer results
For breast cancer, the PAFE
e associated with known envi-
ronmental factors is low. The value of the model is there-
fore less in calculating the utility of targeted
environmental interventions than in exploring the solu-
tion space for a complex disease with RMD close to 2.
Although strictly speaking the classical twin study solu-
tion (with an additive genetic model, pDZ
g = 1/2, and an
additive G-E model, fge = 0) does not exist as a solution, it
might lie within the margin of error of the data. However,
an infinite number of other models also could also fit the
data. The classical twin model result always overestimates
the genetic component of the variance, which reduces as
the gene-environment interaction factor fge increases, and
also as pDZ
g decreases (i.e. as epistatic terms begin to dom-
inate the genetic model). These alternative models imply
that shared environmental factors may partially explain
familial aggregation of breast cancer. This contrasts with
the classical twin method result (see earlier), which for
RMD = 2 leads to the inevitable conclusion that shared sib-
ling risk must be due solely to shared genes [35].
In theory, a model with pDZ
g = 0 (where shared sibling risk
is due entirely to shared environmental factors) could fit
the data. However, for breast cancer the existence of
known mutations that significantly increase risk (particu-
larly mutations in the BRCA1 and BRCA2 genes, which are
relatively common) rules out this solution. Although it is
not possible to subtract out the effect of these mutations
from the model, it is possible to show that they could be
sufficient to explain the twin data if a G-E interaction also
exists. For example, one possible solution consistent with
the data could involve one or more dominant genes (pDZ
g
= 1/2), a strong G-E interaction (fge = 1/PAFE 
e), but a
largely environmental explanation for shared sibling risk
(say cSD/RSD = 0.9). This solution implies that the genetic
component of the variance is less than a fifth of the classi-
cal twin study result, which could be low enough to be
explained by mutations in the BRCA1 and BRCA2 genes
alone [35]. If this model were correct it would have
important implications for women with such mutations,
but would not contribute significantly to reducing the
incidence of breast cancer in the population as a whole,
because the affected proportion of the population γ would
be rather small. Other solutions, involving different
genetic models with lower pDZ
g, and/or less gene-environ-
ment interaction, are also possible.
The line γmax = γmin does not occur within the solution
space for breast cancer; however, in some circumstances
the lines γmax and γmin may be rather close together. This
suggests that, although as expected there is always a trade-
off between selecting a small proportion (γmin) of the pop-
ulation with a high Positive Predictive Value (PPV), or a
larger proportion of the population (γmax) with a higher
Population Impact (PI) [19], some possible solutions
could exist for breast cancer where the PPV and PI are both
relatively high. Further, γmax is often less than 1/2, so that,
in these regions of the possible solution space, maximum
utility might be obtained by targeting less than 50% of the
population. However, known environmental factors for
breast cancer are often not amenable to intervention and
other possible solutions, with low, zero or negative utility,
also exist.
Lung cancer results
For lung cancer, all the possible solutions imply that
shared sibling risk is largely due to shared environmental
factors (smoking) because solutions occur only when cSD/
RSD is close to 1. Unlike for breast cancer, the line γmax =
γmin lies outside the solution space, even for negative fge, as
does the area of solutions with γmaxge < 1/2. However, the
classical twin study solution, with fge = 0 and pDZ
g = 1/2,
clearly lies within the solution space.
Although the classical twin model again provides an
upper limit to the genetic component of the variance,
even the classical result indicates that the risk of lung can-
cer is dominated by smoking in this population and the
variance has at most a small genetic component.
Unlike the breast cancer example, γmax and γmin are always
far apart, suggesting a strong trade off between high Pos-
Table 7: Input variables
Condition λMZ λDZ λsib ε PAFE
e rt
Breast cancer 4.09 2.51 2.01 0.62 0.15 0.036
Lung cancer 6.27 6.14 3.16 0.15 0.86 0.017
Schizophrenia 52.1 14.2 8.6 0.62 0.15 0.01
0.15 0.86Theoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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tive Predictive Value (Rge) for a genotypic test and a high
Population Impact (PI) for a targeted intervention. This
means that a genotypic test that predicts which smokers
will get lung cancer cannot exist. To predict all cases of
lung cancer in smokers (i.e. to obtain PI = 1), 95% or
more of the population would have to be in the high gen-
otypic risk group, and the predictive value of such a test
would be very low.
Because the genetic component of the variance is so small,
it follows that the utility of genetic 'prediction and preven-
tion' (measured by Uge) is also small (from Equation
(28)). Utility is maximum when γ = 1/2, but even then
values are low. The maximum utility of genotyping occurs
when about 60% of cases could be prevented by targeting
the 50% of smokers at high genotypic risk. However,
other possible solutions have zero or negative utility.
Schizophrenia results
For schizophrenia, the classical twin study solution (with
fge = 0 and pDZ
g = 1/2 and cMD = 1) cannot not fit the data.
If the 'equal environments' assumption holds, neither a
single dominant gene (pDZ
g = 1/2), nor additive polygenic
model (also with pDZ
g = 1/2), nor single recessive gene
(pDZ
g = 1/4) can explain the twin and family data, consist-
ent with Risch's 1990 findings [16]. This may suggest that
the genetic model for schizophrenia is likely to be domi-
nated by epistatic terms. However, if gene-environment
interactions are important, it is also possible that a reces-
sive gene, combined with at least multiplicative G-E inter-
action (pDZ
g = 1/4 and fge = 1 or higher), could explain the
data.
The possible solution spaces include purely genetic expla-
nations for shared sibling risk (at cSD/RSD = 0), or purely
environmental ones (at cSD/RSD = 1, applicable if pDZ
g = 0).
Assuming a small environmental component to the vari-
ance, there is no region of the solution space for which
γmaxge < 1/2, suggesting that the utility of targeted environ-
mental interventions under these assumptions is likely to
be low. However, if the environmental component of the
variance is assumed to be much larger, the available solu-
tion space changes dramatically, because the line γmax =
γmin now constrains the solution space to a much smaller
area, which excludes solutions with no G-E interaction (fge
= 0). Special solutions may exist along the line γmax = γmin,
as shown in Table 5. Because the environmental factors
contributing to schizophrenia are unknown, it is impossi-
ble to draw any conclusions about the potential benefits
of targeting environmental interventions at those at high
genotypic risk.
Because prenatal development is thought to be important
in schizophrenia, it is plausible that monozygotic twins
are more likely to share environmental risk factors than
dizygotic twins are. Breaking the 'equal environments'
assumption changes the shape of the solution space sig-
nificantly, and, assuming a small environmental compo-
nent to the variance, only limited G-E interactions are
now possible (the multiplicative G-E model, fge = 1, lies
largely outside the solution space). The utility of targeting
environmental interventions by genotype is then likely to
be low. However, in these circumstances it is possible that
an additive genetic model (pDZ
g = 1/2) with some G-E
interaction, or a recessive gene (pDZ
g = 1/4) with no G-E
interaction, could explain the data.
Discussion
If Fisher's polygenic model [26] is abandoned, along with
the usual twin study assumption that there are no gene-
environment interactions, the four-category model devel-
oped by Khoury and others can be combined with twin,
family and environmental data to implement a 'top down'
approach to assessing the utility of targeting environmen-
tal/lifestyle interventions by genotype. Scoping studies,
valid when RSD ≠ 1, provide a first step to modelling the
health of populations [23].
Abandoning Fisher's assumption that the polygenic
model is necessarily dominated by an additive term can
be justified by the growing evidence that phenotypic
effects can result from the synergistic action of alleles in
many genes [36]. For example, Bardet-Biedl Syndrome,
historically assumed to be a recessive trait, has been
shown to involve three interacting mutations at two loci
in some patients (implying that pDZ
g = 1/8) and, more
recently, an additional locus has been identified that can
also interact to change disease severity and symptoms
[37]. Both positive and negative gene-environment inter-
actions have also been observed in human diseases,
although there are difficulties in confirming their statisti-
cal validity [38,39].
The model also allows the impact of the much criticised
'equal environments' assumption to be explored.
A number of conclusions can be drawn about the merits
of the classical twin study and the utility of genetic 'predic-
tion and prevention'.
Firstly, the model confirms that the classical twin study
solution is not always valid and gives at best an upper
limit to the genetic component of the variance of a trait.
The importance of the 'equal environments' assumption
and of gene-environment interactions have previously
been recognised [17,18]; however, less attention has been
paid to the potential role of gene-gene interactions
(epistasis). For larger values of RMD (greater than 1+RSD),
observed for conditions such as schizophrenia, the modelTheoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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generalizes Risch's findings [16] to show that the three
assumptions of the classical twin model cannot all be sat-
isfied simultaneously. For intermediate RMD  values,
observed for conditions such as breast cancer (for which
RMD is approximately 2), the model illustrates that the
conclusion drawn from classical twin studies, that familial
aggregation is due entirely to shared genetic factors, may
be erroneous. This raises the possibility – previously
rejected on the basis of twin study results [35] – that
genetic variants are important in determining risk only for
the relatively rare familial forms of cancer. If so, genetic
models of familial aggregation (for example [40]) may be
incorrect and the hunt for additional susceptibility genes
could be largely fruitless. Existing published findings
might then reflect prevailing bias, rather than true associ-
ations [14].
Secondly, the model confirms that the potential for reduc-
ing the incidence of common diseases using environmen-
tal/lifestyle interventions targeted by genotype may be
limited [7] by:
(i) the low importance of genetic differences in determin-
ing the risk of some conditions (for example, lung can-
cer);
(ii) the complexity of gene-gene and gene-environment
interactions and/or lack of knowledge of environmental
factors (for example, schizophrenia).
Targeting environmental/lifestyle interventions at those at
'high genotypic risk' can be of high utility only in specific
circumstances. The utility of targeting environmental
interactions by genotype (compared to randomly select-
ing the same number of people from the population) is
zero if there is no gene-environment interaction. Utility
can also be negative in the presence of a negative interac-
tion (i.e. if the people at high genotypic risk have less to
gain  by the intervention than people at low genotypic
risk). The finding that utility increases with gene-environ-
ment interaction is consistent with Khoury and Wagener
[19] but the relationship is considerably clarified by the
adoption here of different measures of the population
attributable fraction associated with a targeted interven-
tion (PAFE
ge) and of utility (Uge). Further, by formally
introducing constraints on the model (for example, that
risks are positive and do not exceed 100%), it is possible
to demonstrate that both the gene-environment interac-
tion factor and utility have maximum values, which can-
not be exceeded for a given data set.
The lung cancer example is apparently trivial but also of
critical importance. The RMD value for lung cancer is close
to 1, and neither the Scandinavian data used here [31],
nor earlier US studies [41], have identified a significant
heritable component. It follows from Equation (27) that
if the genetic component of the variance, Vg, is zero, Vge
(the G-E component of the variance) is also zero and
using genotyping to target an intervention such as smok-
ing cessation is therefore of zero utility (no better than
randomly selecting the same number of individuals). This
approximate conclusion is confirmed by the results pre-
sented for lung cancer, which show extremely low utility.
The detailed calculations may at first sight seem unneces-
sary, particularly because smoking causes multiple dis-
eases and targeting smoking cessation on the basis of lung
cancer risk alone is therefore ill-advised. However, the
idea that a genetic test will one day predict which smokers
get lung cancer has been widely promoted in the literature
and has driven much research aimed at identifying the
supposed 'genes for lung cancer' [42]. The results pre-
sented here strongly suggest that there will never be a
genetic or genotypic test that predicts which smokers will
get lung cancer, because the genetic component of the var-
iance is not high enough.
Finally, the model illustrates the argument of Terwilliger
and Weiss [11] that the potential for population biobanks
to quantify risks for complex disease is limited by a 'mul-
tiple testing' problem caused by the large number of
genetic and gene-environment interaction models that
could fit existing data. Each point in each solution space
described above represents a different combination of a
genetic risk model (defined by pDZ
g) and a G-E interaction
model (defined by fge). Further, any given value of pDZ
g
may be obtained by an infinite number of different com-
binations of different alleles acting through multiple bio-
logical pathways. Because the number of hypotheses that
could be tested is essentially infinite, sample sizes neces-
sary to quantify the risks (Roo, Rgo, Roe and Rge) could
"plausibly be larger than the number of people that have ever
lived" [11].
The model has several limitations. Measurements of
shared sibling risk (λsib) are needed from the same popu-
lation as twin data, and the scoping studies are only valid
for λDZ > λsib, implying that environmental risks are more
strongly correlated in dizygotic twins than other siblings.
Some data exist to support this assumption for smoking
[43] but for other exposures its validity is usually
unknown. However, the model does not reduce to the
classical twin study solution if this condition is not met:
instead, data from more relatives are needed. In principle
the model could, and should, be expanded to include data
from more relatives, other data (such as migration study
data), more risk categories and error terms. However, the
number of unknown parameters will then increase, unless
more data are available to quantify exposures (which
change from generation to generation) and to estimateTheoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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the extent to which environments are correlated between
different types of relative.
Treating exposure and environmental variance (or popu-
lation attributable fraction) as input data is also problem-
atic when the effects of environmental factors on risk are
often unknown. Further, the simple nature of the model
(with one environmental axis) cannot adequately repre-
sent the complexity of environmental (including socio-
economic) causes of disease. However, if targeting envi-
ronmental interventions by genotype is to be considered,
this implies that at least something is known (or expected
to be learned) about environmental factors, such as partic-
ular exposures, that are amenable to intervention.
The assumption of no gene-environment correlation will
often hold (for example it is rather implausible that the
same genes strongly influence both lung cancer risk and
nicotine addiction), but is not necessarily always true.
Adult lactose intolerance is an example of a condition
with a strong gene-environment interaction where tar-
geted intervention to avoid drinking milk may be of high
utility. However, the model is invalid for lactose intoler-
ance unless exposures are applied equally to the popula-
tion studied because, in general, people who are lactose
intolerant may be less likely to drink milk (a gene-envi-
ronment correlation) owing to the unpleasant symptoms.
A more fundamental problem is caused by the assump-
tions that: (i) the risks Roo, Rgo, Roe and Rge are inherent
properties of a given trait within a given population (with
a given γ and ε) and that there are therefore no confound-
ers; and (ii) risks are randomly distributed within these
categories.
These assumptions, although often made, are implausible
in many situations. The assumption of no confounders
means that the model can only represent a subset of the
potential models of gene-gene and gene-environment
interaction described by more complex models (for exam-
ple [17]). It is unlikely to be met if multiple genetic factors
interact with multiple environmental ones [44]. Although
this may well render the results presented here invalid,
such complexity is likely to reduce the utility of targeting
by genotype, rather than enhance it. Hence, situations
where the 'no confounders' assumption at least approxi-
mately holds are those most likely to be of relevance to
public health.
The second assumption neglects the fact that for most
exposures there is a gradient in risk, with higher exposure
meaning higher risk, and that the same may also be true
of genetic factors. This means that increasing the number
of categories in the model will increase Ve (see [45]) and
perhaps Vg. Further, these subcategories may be differ-
ently correlated between relatives (for example, the twin
of a heavy smoker may be more likely to be a heavy
smoker than a light one). If so, a relative of a proband may
not be representative of their allocated risk category in the
four-category model and Equation (22) then becomes
invalid.
More broadly, these assumptions make the model, like
the classical twin model, essentially deterministic: it
assumes that all the factors contributing to correlations in
risk between relatives are perfectly known and are either
environmental or genetic. Retention of these assumptions
here may be problematic and could limit the applicability
of the results. Nevertheless, all the other questionable
assumptions of the classical twin model have been simul-
taneously removed.
Conclusion
The model shows that the potential for reducing the inci-
dence of common diseases using environmental interven-
tions targeted by genotype may be limited, except in
special cases. The model also confirms that the impor-
tance of an individual's genotype in determining their risk
of complex diseases tends to be exaggerated by the classi-
cal twin studies method, owing to the 'equal environ-
ments' assumption and the assumption of no gene-
environment interaction. In addition, if phenotypes are
genetically robust, because of epistasis, a largely environ-
mental explanation for shared sibling risk is plausible,
even if the classical heritability is high. The model there-
fore highlights the possibility – previously rejected on the
basis of twin study results – that inherited genetic variants
are important in determining risk only for the relatively
rare familial forms of diseases such as breast cancer. If so,
genetic models of familial aggregation may be incorrect
and the hunt for additional susceptibility genes could be
largely fruitless.
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Appendix A: formal derivation of equation (31)
Equation (23) may be derived more formally by extend-
ing the matrix method of Li and Sacks [46].
Define the probability that an affected proband is in gen-
otypic risk category z and environmental risk category w
as Pzw and assume that risks are randomly distributed
within categories. Using the definitions of the four cate-
gory model given in Table 1, a vector P may be defined:Theoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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A risk vector R may also be defined:
Now define Gxy as the conditional probability P(relative is
in genotypic risk category y|proband is in genotypic risk
category x). Similarly, define Exy as the conditional proba-
bility P(relative is in environmental risk category
y|proband is in environmental risk category x). Using the
definitions of prel
g and prel
e given in Section 2.5, matrices
G and E may be written such that:
Finally, define Xab-cd as the conditional probability P(rela-
tive is in risk category cd|proband is in risk category ab),
where the risk categories are as defined in Table 1 (for
example risk categorgy 'ge' implies high-genotypic and
high-environmental risk). Provided prel
g and prel
e are inde-
pendent (there are no gene-environment correlations),
the gene-environment interaction matrix Mrel
ge may be
written as:
Then the risk in a relative of the proband is given by:
After some algebra, this yields equation (23).
Appendix B: calculating recurrence risks for 
twins
The sibling recurrence risk λsib is often available directly
from familial studies. For twins the recurrence risks, if not
reported, may be calculated from the case-wise concord-
ance (Cc):
λMZ = CcMZ /rt   (B1)
λDZ = CcDZ /rt   (B2)
where, if there is complete ascertainment of all affected
twins in a population,
Cc = 2C/(2C + D)   (B3)
and C is the number of concordant and D the number of
discordant pairs [25].
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Additional File 1
Gene-gene and gene-environment interaction model. Contains the Visual 
Basic macro (Twincal), input and output datasheets and charts used to 
calculate the solutions described in the text. The program is run by enter-
ing parameters in the 'Inputs' sheet and clicking on the 'Run' button. Note 
that for the final chart ('fe') the number of categories on the horizontal 
axis changes depending on the environmental input parameters ε and 
PAFE
e. If these parameters are changed it is therefore necessary to delete 
the lower part of the output sheet prior to running the model and, after the 
run, to redraw the chart using the source data option from the chart. All 
other charts are drawn automatically. The line γmax = γmin is calculated 
exactly for the chart 'fe' but is approximated in the charts 'pgdz' and 
'pgdzneg' using Newton's method and an initial guess for fge (f0) and step 
(fet). For some input parameters it may be necessary to change these val-
ues by editing the Visual Basic code (Twincal) to obtain a valid solution.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S1.xls]
Additional File 2
Supplementary Figure 1: Example model solution space with RMD = 1.7 
and Uge ≥ 0. Model solution space with Uge ≥ 0 for the same input param-
eters as Figure 2, apart from λMZ = 4.4.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S2.bmp]
Additional File 3
Supplementary Figure 2: Example model solution space with RMD = 1.8 
and Uge ≥ 0. Model solution space with Uge ≥ 0 for the same input param-
eters as Figure 2, apart from λMZ = 4.6.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S3.bmp]
Additional File 4
Supplementary Figure 3: Example model solution space with RMD = 1.95 
and Uge ≥ 0. Model solution space with Uge ≥ 0 for the same input param-
eters as Figure 2, apart from λMZ = 4.9.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S4.bmp]Theoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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Additional File 5
Supplementary Figure 4: Example model solution space with RMD = 2.1 
and Uge ≥ 0. Model solution space with Uge ≥ 0 for the same input param-
eters as Figure 2, apart from λMZ = 5.2.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S5.bmp]
Additional File 6
Supplementary Figure 5: Example full solution space with RMD = 1.7. Full 
model solution space for the same input parameters as Figure 5, trans-
formed so that fge is on the horizontal axis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S6.bmp]
Additional File 7
Supplementary Figure 6: Example full solution space with RMD = 1.8. Full 
model solution space for the same input parameters as Figure 6, trans-
formed so that fge is on the horizontal axis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S7.bmp]
Additional File 8
Supplementary Figure 7: Example full solution space with RMD = 1.95. 
Full model solution space for the same input parameters as Figure 7, trans-
formed so that fge is on the horizontal axis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S8.bmp]
Additional File 9
Supplementary Figure 8: Example full solution space with RMD = 2.1. Full 
model solution space for the same input parameters as Figure 8, trans-
formed so that fge is on the horizontal axis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S9.bmp]
Additional File 10
Supplementary Figure 9: Example model solution with cMD > 1 and Uge ≥ 
0. Input parameters: λMZ = 5.2, λDZ = 3, λsib = 2, ε = 0.2, PAFE
e = 0.5, 
cMD = 2, rt = 0.1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S10.bmp]
Additional File 11
Supplementary Figure 10: Example model solution with cMD > 1 and Uge 
≥ 0. Input parameters as for Figure 13.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S11.bmp]
Additional File 12
Supplementary Figure 11: Example full solution space with cMD > 1. Full 
model solution space for the same parameters as Figure 13, transformed 
so that fge is on the horizontal axis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S12.bmp]
Additional File 13
Supplementary Figure 12: Breast cancer solution space with Uge ≥ 0. Input 
parameters are as shown in Table 5, with cMD = 1. The solution space is 
shown (shaded) for positive fge, assuming the 'equal environments' 
assumption holds (cMD = 1). The darker shaded area shows the part of the 
solution space for which γmaxge < 1/2. Utility Uge is at its maximum when 
γ = 1/2 except within this darker shaded area.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S13.bmp]
Additional File 14
Supplementary Figure 13: Breast cancer variances with fge = 0. Input 
parameters as for Figure 16. Additive model of G-E interaction (fge = 0). 
Variance components are genetic (Vg) or environmental (Ve).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S14.bmp]
Additional File 15
Supplementary Figure 14: Breast cancer variances with fge = 1. Input 
parameters as for Figure 16. Multiplicative G-E interaction model (fge = 
1). Variance components are genetic (Vg), environmental (Ve) or due to 
gene-environment interaction (Vge).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S15.bmp]
Additional File 16
Supplementary Figure 15: Breast cancer variances with fge = 1/PAFE
e. 
Input parameters as for Figure 16. Maximum G-E interaction model (fge 
= 1/PAFE
e). Variance components are genetic (Vg), environmental (Ve) 
or due to gene-environment interaction (Vge).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S16.bmp]
Additional File 17
Supplementary Figure 16: Breast cancer γ values with fge = 0. Input 
parameters as for Figure 16. The proportion of the population in the 'high 
genotypic risk' group, γ, may take any value in the shaded area. γmin occurs 
when Rge = 1, i.e. when the Positive Predictive Value (PPV) of being in 
the 'ge' subgroup is 100%. γmax occurs when Roo = 1 for an additive G-E 
model and solutions with a Population Impact of 100% (PI = 1) cannot 
exist.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S17.bmp]
Additional File 18
Supplementary Figure 17: Breast cancer γ values with fge = 1. Input 
parameters as for Figure 16. The proportion of the population in the 'high 
genotypic risk' group, γ, may take any value in the shaded area. A solution 
with a Population Impact of 100% (PI = 1) may exist if γ = γmax.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S18.bmp]Theoretical Biology and Medical Modelling 2006, 3:35 http://www.tbiomed.com/content/3/1/35
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Additional File 19
Supplementary Figure 18: Breast cancer γ values with fge = 1/PAFE
e. Input 
parameters as for Figure 16. The proportion of the population in the 'high 
genotypic risk' group, γ, may take any value in the shaded area. A solution 
with a Population Impact of 100% (PI = 1) may exist if γ = γmax.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S19.bmp]
Additional File 20
Supplementary Figure 19: Breast cancer solution space with Uge ≤ 0. Input 
parameters are as for Figure 16. The solution space is shown for negative 
fge (where the utility of targeting environmental interventions at the high 
genotypic risk group is negative, Uge ≤ 0). Solutions exist only in the 
shaded area where γmax ≥ γmin.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S20.bmp]
Additional File 21
Supplementary Figure 20: Breast cancer: full solution space. Input param-
eters are as for Figure 16. The same solution space as Figures 16 and 23 
is shown (shaded), transformed so that the G-E interaction factor is plot-
ted on the horizontal axis. Again, each point in the shaded solution space 
represents a genetic model defined by pDZ
g and a G-E interaction model 
defined by fge. The area of solutions with γmaxge < 1/2 is highlighted with 
darker shading. The classical twin study solution lies on the vertical axis 
(fge = 0) at the point pDZ
g = 1/2, and is slightly outside the solution space.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S21.bmp]
Additional File 22
Supplementary Figure 21: Lung cancer solution space with Uge ≥ 0. Input 
parameters are as shown in Table 5, with cMD = 1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S22.bmp]
Additional File 23
Supplementary Figure 22: Lung cancer variances with fge = 0. Input 
parameters as for Figure 25. Note that the horizontal axis has been 
expanded to show high values of cSD/RSD only.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S23.bmp]
Additional File 24
Supplementary Figure 23: Lung cancer variances with fge = 1. Input 
parameters as for Figure 25. Note that the horizontal axis has been 
expanded to show high values of cSD/RSD only.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S24.bmp]
Additional File 25
Supplementary Figure 24: Lung cancer variances with fge = 1/PAFE
e. 
Input parameters as for Figure 25. Note that the horizontal axis has been 
expanded to show high values of cSD/RSD only.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S25.bmp]
Additional File 26
Supplementary Figure 25: Lung cancer γ values for fge = 1. Input param-
eters as for Figure 25. The proportion of the population in the 'high geno-
typic risk' group, γ, may take any value in the shaded area.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S26.bmp]
Additional File 27
Supplementary Figure 26: Lung cancer γ values for fge = 1/PAFE
e. Input 
parameters as for Figure 25. The proportion of the population in the 'high 
genotypic risk' group, γ, may take any value in the shaded area.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S27.bmp]
Additional File 28
Supplementary Figure 27: Lung cancer Uge values for fge = 1. Input param-
eters as for Figure 25. The utility parameter, Uge, may take any value in 
the shaded area, but is maximum when γ = 1/2.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S28.bmp]
Additional File 29
Supplementary Figure 28: Lung cancer Uge values for fge = 1/PAFE
e. Input 
parameters as for Figure 25. The utility parameter, Uge, may take any 
value in the shaded area, but is maximum when γ = 1/2.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4682-3-35-S29.bmp]
Additional File 30
Supplementary Figure 29: Lung cancer: full solution space. Input param-
eters as for Figure 25.
Click here for file
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Additional File 31
Supplementary Figure 30: Schizophrenia Uge ≥ 0, small environmental 
variance and cMD ≥ 1. Input parameters are as shown in Table 5, with ε 
= 0.62, PAFE
e = 0.15 and cMD = 1.
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Additional File 32
Supplementary Figure 31: Schizophrenia Uge ≥ 0, small environmental 
variance and cMD > 1. Input parameters are as shown in Table 5, with ε 
= 0.62, PAFE
e = 0.15 and cMD = 3.8.
Click here for file
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